Dividend Growth Stocks: Pepsi and Coca-Cola

In the article we will take a closer look at two dividend growth stocks. The battle between the Coca-Cola Company (KO) and PepsiCo (PEP) has waged on for decades, but in spite of what is a decidedly saturated market these two companies are still running neck and neck.

Warren Buffett


Coca-Cola has a $154.31 billion market cap. On February 7, the soft drink giant announced quarterly performance that trumped analyst expectations. It had quarterly revenue of $11 billion, edging out analyst estimates of $10.99 billion, and an EPS of 79 cents a share for Q4 2011, beating out analyst estimates of 77 cents a share for the period. Two days later, on February 9, the $99.98 billion market cap PepsiCo announced its Q4 2011 performance. The company reported revenues of $20.16 billion for the period and earnings per share of $1.15, compared to analyst estimates of $19.92 billion in revenue and earnings of $1.13 per share.

However, while these companies are beating analyst expectations right now, their ability to do so going forward is uncertain. On the one hand, the market is saturated, so increasing revenues will either be a matter of cutting costs or expanding into emerging markets. On the other hand, public opinion toward soft drinks, and even bottled water is rapidly changing. Domestic soft drinks have shrunk roughly 1 percent, and no wonder. Soft drinks have been linked to a variety of diseases, including asthma, type 2 diabetes, and even cancer – not to mention a higher waist circumference. Regarding bottled water, there have been a variety of studies that show that it isn’t necessarily better or even safer than regular tap water. Between that, environmental concerns about where all those plastic bottles go, and concerns about plastics in general, consumers are increasingly using aluminum or glass bottles and their own filtration systems. In other words, the market for Coke and Pepsi’s offerings are shrinking. Point in case, both companies were downgraded from buy to hold or neutral recently – UBS downgraded Coke on January 11 while Pepsi was downgraded by Stifel Nicolaus on September 23. That hasn’t changed hedge fund manager interest in the soft drink industry – Warren Buffett’s Berkshire Hathaway still has almost 23 percent of its portfolio or $13.5 billion in Coke, and both Kerr Neilson’s Platinum Asset Management and Nelson Peltz’s Trian Partners has stakes in Pepsi valued at more than 5 percent of their portfolios – but it is an issue that long-term investors need to consider.

Both Coke and Pepsi have solid dividends and fair expected growth, but expectations over their future earnings leaves something to be desired. Coke closed trading Friday at just under $68 a share, on a one-year target estimate of $75.62. The company pays a $1.88 dividend (2.80 percent yield). Analysts estimate the company’s earnings will grow by an average of 6.37 percent per annum over the next five years, versus expectations of 12.94 percent for its industry and 13.39 percent for its sector. Pepsi was trading at just under $64 a share, with a one-year target estimate of $69.17. It pays a $2.06 dividend, a 3.20 percent yield at its current price. Analysts estimate that Pepsi’s earnings will grow by 6.15 percent per annum over the next five years, falling just short of Coke’s estimates.

We recommend Pepsi as a hold and Coke as a short-term position at best if you are after large capital gains. Technology stocks such as Apple (AAPL) and Microsoft (MSFT) have more attractive price multiples with higher expected EPS growth rates. However, if you are a long-term dividend growth investor these two stocks are great alternatives to long-term bonds. Pepsi increased its quarterly dividend from $0.15 to $0.515 over the last 10 years. Coca-Cola had a slightly lower growth rate. Quarterly dividends increased from $0.20 to $0.47 since 2002. Both stocks have stable businesses and low dividend coverage ratios, so dividends seem safe too.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!